SCHEMBL460847

SCHEMBL460847

O=c1[nH]c2ccccc2c2c1ccc1ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.57
▸ PARP1 P09874 4/20 0.57
▸ ALDH1A1 P00352 3/20 0.57
▸ TNKS O95271 2/20 0.57
▸ TNKS2 Q9H2K2 2/20 0.57
▸ LMNA P02545 2/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ GPR3 P46089 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ PMP22 Q01453 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ PARP15 Q460N3 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ CDK4 P11802 3/20 0.56
▸ CCND1 P24385 3/20 0.56
▸ CCNB2 O95067 1/20 0.56
▸ CCNE2 O96020 1/20 0.56
▸ PRKCG P05129 1/20 0.56
▸ PRKCB P05771 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2325768 0.85 PARP1 (0.47) KDM4EPARP1ALDH1A1TNKSTNKS2
SCHEMBL23132411 0.81 PARP1 (0.57) KDM4EPARP1ALDH1A1TNKSTNKS2
SCHEMBL500585 0.78 PARP1 (0.49) KDM4EPARP1ALDH1A1TNKSTNKS2
SCHEMBL17072688 0.78 CDK4 (0.65) ALDH1A1MEN1GPR3KMT2AHSD17B10
SCHEMBL20227597 0.77 KDM4E (0.44) KDM4EPARP1ALDH1A1TNKSTNKS2
SCHEMBL10945861 0.76 CDK4 (0.63) MEN1KMT2ACDK4CCND1CCNB2
SCHEMBL17071327 0.76 KIF11 (0.65) MEN1KMT2ACDK4CCND1CCNB2
SCHEMBL29385261 0.76 CDK4 (0.68) KDM4EPARP1ALDH1A1LMNAMEN1
SCHEMBL257083 0.76 CDK4 (0.68) KDM4EPARP1ALDH1A1LMNAMEN1
SCHEMBL23132387 0.76 CDK4 (0.58) KDM4EPARP1ALDH1A1TNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 — — US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 — — US disclosed
EP-2387564-A1 BENZO ÝC¨PHENANTHRIDINES AS ANTIMICROBIAL AGENTS Rutgers, The State University of New Jersey (US) 2011-11-23 — — EP disclosed
US-8037884-B2 Modular system for patient positioning during medical procedures ALLEN MEDICAL SYSTEMS, INC. (US) 2011-10-18 — — US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH KDM4E 536/4885PARP1 1409/4885ALDH1A1 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback